Eli Lilly - 47 Year Stock Price History | LLY

Historical daily share price chart and data for Eli Lilly since 1972 adjusted for splits. The latest closing stock price for Eli Lilly as of October 18, 2019 is 108.64.
  • The all-time high Eli Lilly stock closing price was 131.02 on March 26, 2019.
  • The Eli Lilly 52-week high stock price is 132.13, which is 21.6% above the current share price.
  • The Eli Lilly 52-week low stock price is 104.17, which is 4.1% below the current share price.
  • The average Eli Lilly stock price for the last 52 weeks is 115.35.
Eli Lilly Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 116.2160 114.8800 131.0200 106.7900 108.6400 -6.12%
2018 93.6390 84.6800 118.6400 74.2100 115.7200 37.01%
2017 82.2041 74.6000 87.8900 74.5800 84.4600 14.83%
2016 76.3822 82.8700 84.1100 65.9700 73.5500 -12.71%
2015 78.7990 70.0600 89.9800 68.4100 84.2600 22.13%
2014 61.6510 50.7300 72.8300 50.7300 68.9900 35.27%
2013 52.6862 49.5100 58.3300 47.6500 51.0000 3.41%
2012 43.5621 41.8000 53.8100 38.4900 49.3200 18.67%
2011 36.8431 35.0000 41.7500 33.6300 41.5600 18.61%
2010 35.1512 35.8200 38.0600 32.2500 35.0400 -1.88%
2009 34.3321 40.5700 40.5700 27.4700 35.7100 -11.32%
2008 45.5674 52.5500 57.1800 29.9100 40.2700 -24.57%
2007 55.4875 52.2500 60.5600 49.0900 53.3900 2.48%
2006 55.0888 57.3600 58.8600 50.4100 52.1000 -7.93%
2005 55.0222 56.2500 60.4400 49.7600 56.5900 -0.28%
2004 65.8781 71.2400 76.2600 50.4400 56.7500 -19.31%
2003 63.5121 66.2400 73.8900 53.7000 70.3300 10.76%
2002 64.8852 78.5000 80.6900 48.1500 63.5000 -19.15%
2001 79.7423 91.5000 91.5000 72.5900 78.5400 -15.60%
2000 78.6936 65.5600 108.5000 54.5000 93.0600 39.94%
1999 75.6695 86.0000 97.4400 61.5000 66.5000 -25.18%
1998 71.3715 68.9400 90.8800 58.2500 88.8800 27.65%
1997 52.6450 36.2500 69.9400 36.2500 69.6300 90.77%
1996 31.5319 27.6900 39.6250 24.7500 36.5000 29.78%
1995 20.0601 16.3125 28.2500 15.7200 28.1250 71.44%
1994 14.1005 14.8450 16.4050 11.8750 16.4050 10.51%
1993 12.9077 15.3450 15.3450 10.9050 14.8450 -2.26%
1992 17.1063 21.2200 21.7800 14.7200 15.1875 -27.25%
1991 19.3920 18.1875 21.2200 17.2500 20.8750 13.99%
1990 17.9158 17.1875 22.4375 14.7800 18.3125 6.93%
1989 14.2108 10.7025 17.1250 10.7025 17.1250 60.23%
1988 10.3627 9.9688 11.4525 8.8750 10.6875 9.62%
1987 10.9973 9.2813 13.0775 7.7500 9.7500 5.05%
1986 8.7253 6.8594 10.3125 6.3594 9.2813 33.18%
1985 5.3010 4.0550 6.9688 4.0469 6.9688 68.94%
1984 3.8056 3.7188 4.1800 3.3750 4.1250 14.03%
1983 3.9157 3.5863 4.2738 3.5469 3.6175 0.66%
1982 3.5566 3.4844 4.0625 2.9063 3.5938 2.68%
1981 3.6454 3.9375 4.2656 2.9138 3.5000 -11.98%
1980 3.3308 3.6250 3.9763 2.8825 3.9763 6.71%
1979 3.4567 3.0000 3.9688 2.9763 3.7263 24.86%
1978 2.8123 2.3594 3.3594 2.2969 2.9844 26.06%
1977 2.4252 2.9450 2.9450 2.0550 2.3675 -20.45%
1976 3.2237 3.1950 3.7500 2.7263 2.9763 -7.75%
1975 4.1097 4.1950 4.9450 3.1800 3.2263 -24.09%
1974 4.3344 4.5863 5.1325 3.5156 4.2500 -8.11%
1973 5.1006 4.9450 5.7263 4.3825 4.6250 -7.06%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $104.711B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $359.375B 15.53
Roche Holding AG (RHHBY) Switzerland $250.381B 0.00
Merck (MRK) United States $214.559B 17.64
Pfizer (PFE) United States $201.662B 11.88
Novartis AG (NVS) Switzerland $199.914B 17.20
Novo Nordisk (NVO) Denmark $124.746B 22.04
Sanofi (SNY) France $116.442B 14.31
AstraZeneca (AZN) United Kingdom $115.787B 22.40
AbbVie (ABBV) United States $111.093B 8.90
GlaxoSmithKline (GSK) United Kingdom $105.929B 13.31
Bristol-Myers Squibb (BMY) United States $85.747B 12.16
Bayer (BAYRY) Germany $68.188B 9.93
H Lundbeck (HLUYY) Denmark $6.714B 9.69